由于印度制造商 Brassica Pharma 的卫生条件不佳，FDA 召回了 Equate 和 CVS Health 的眼膏。 FDA recalls eye ointments by Equate, CVS Health due to unsanitary conditions at Indian manufacturer Brassica Pharma.

由于印度一家生产工厂的卫生条件不佳，包括 Equate 和 CVS Health 在内的多个品牌的眼膏正在被 FDA 召回。 Eye ointments by multiple brands, including Equate and CVS Health, are being recalled by the FDA due to unsanitary conditions at a manufacturing facility in India. 位于塞恩的制造商 Brassica Pharma Pvt. The Thane-based manufacturer, Brassica Pharma Pvt. 在联邦检查员发现该工厂存在不卫生条件后，该公司正在自愿召回这些产品。 Ltd., is voluntarily recalling the products after federal inspectors found unsanitary conditions at the facility. 这些药膏通过产品分销商沃尔玛、CVS 和 AACE Pharmaceuticals 在全国范围内分发给批发商、零售商，它们是无菌的，存在眼部感染或相关伤害的潜在风险。 The ointments, which were distributed nationwide to wholesalers, retailers, and through the product distributors Walmart, CVS, and AACE Pharmaceuticals, are intended to be sterile and pose a potential risk of eye infections or related harm.